The ineffective management of the infant formula shortfall that occurred in 2022 by the Biden administration is now reportedly the target of a new investigation from the House Oversight and Accountability Committee.
Rep. James Comer (R-KY), Chairman of the Oversight Committee, and Rep. Lisa McClain (R-MI), Chairwoman of the Subcommittee on Health Care and Financial Services, have written a letter to FDA Commissioner Dr. Robert Califf, requesting documents related to the government’s response to the nationwide baby formula shortage.
The letter was sent by the Oversight Committee Chairman.
The two congressmen were extremely critical of the Food and Drug Administration for not accepting any real blame for the way it handled the problem.
“The Committee on Oversight and Accountability is continuing its investigation into the U.S. Food and Drug Administration’s (FDA) response to the infant formula shortage and its restructuring of the food and nutrition division in response to the infant formula shortage,” a letter from Comer and McClain read.
Comer and McClain criticize the Food and Drug Administration for reorganizing the food safety and nutrition division rather than terminating or reassigning the personnel who botched their handling of the issue.
The Committee subsequently asked that the FDA give over a plethora of records connected to the issue.
These materials included documentation and contacts between different relevant parties, such as the White House under the administration of President Joe Biden.
The Committee is demanding that all the relevant materials be turned over by the Biden Administration by April 4th.
